Levine MS - Search Results

1

Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.

Wang N, Gray M, Lu XH, Cantle JP, Holley SM, Greiner E, Gu X, Shirasaki D, Cepeda C, Li Y, Dong H, Levine MS, Yang XW. Wang N, et al. Among authors: levine ms. Nat Med. 2014 May;20(5):536-41. doi: 10.1038/nm.3514. Epub 2014 Apr 28. Nat Med. 2014. PMID: 24784230 Free PMC article.

2

Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.

Holley SM, Galvan L, Kamdjou T, Cepeda C, Levine MS. Holley SM, et al. Among authors: levine ms. Eur J Neurosci. 2019 Jan;49(1):79-93. doi: 10.1111/ejn.14283. Epub 2018 Dec 10. Eur J Neurosci. 2019. PMID: 30472747 Free PMC article.

3

Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Cepeda C, Levine MS. Cepeda C, et al. Among authors: levine ms. Neuroscientist. 2022 Feb;28(1):20-40. doi: 10.1177/1073858420972662. Epub 2020 Nov 16. Neuroscientist. 2022. PMID: 33198566 Free PMC article.

4

Neurophysiological Assessment of Huntington's Disease Model Mice.

Donzis EJ, Holley SM, Cepeda C, Levine MS. Donzis EJ, et al. Among authors: levine ms. Methods Mol Biol. 2018;1780:163-177. doi: 10.1007/978-1-4939-7825-0_9. Methods Mol Biol. 2018. PMID: 29856019

5

Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.

Wood TE, Barry J, Yang Z, Cepeda C, Levine MS, Gray M. Wood TE, et al. Among authors: levine ms. Hum Mol Genet. 2019 Feb 1;28(3):487-500. doi: 10.1093/hmg/ddy363. Hum Mol Genet. 2019. PMID: 30312396 Free PMC article.

6

The corticostriatal pathway in Huntington's disease.

Cepeda C, Wu N, André VM, Cummings DM, Levine MS. Cepeda C, et al. Among authors: levine ms. Prog Neurobiol. 2007 Apr;81(5-6):253-71. doi: 10.1016/j.pneurobio.2006.11.001. Epub 2006 Dec 13. Prog Neurobiol. 2007. PMID: 17169479 Free PMC article. Review.

7

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.

Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW. Gray M, et al. Among authors: levine ms. J Neurosci. 2008 Jun 11;28(24):6182-95. doi: 10.1523/JNEUROSCI.0857-08.2008. J Neurosci. 2008. PMID: 18550760 Free PMC article.

8

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.

Cepeda C, Cummings DM, André VM, Holley SM, Levine MS. Cepeda C, et al. Among authors: levine ms. ASN Neuro. 2010 Apr 7;2(2):e00033. doi: 10.1042/AN20090058. ASN Neuro. 2010. PMID: 20396376 Free PMC article. Review.

9

Dopamine and glutamate in Huntington's disease: A balancing act.

André VM, Cepeda C, Levine MS. André VM, et al. Among authors: levine ms. CNS Neurosci Ther. 2010 Jun;16(3):163-78. doi: 10.1111/j.1755-5949.2010.00134.x. Epub 2010 Apr 8. CNS Neurosci Ther. 2010. PMID: 20406248 Free PMC article. Review.

10

Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.

Cummings DM, Cepeda C, Levine MS. Cummings DM, et al. Among authors: levine ms. ASN Neuro. 2010 Jun 18;2(3):e00036. doi: 10.1042/AN20100007. ASN Neuro. 2010. PMID: 20585470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

686 results

Search Page

Filters